Investigando en Diabetes Marzo 2023

Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study. Martínez-Montoro JI, Picón-César MJ, Simón-Frapolli VJ, Pinzón-Martín JL,...